| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |